PharmaShots | Incisive News in 3 Shots

Subscribe Now

CNS Diseases

PeptiDream and Takeda Expand its Research and License Agreement to Develop Peptide Drug Conjugates Targeting CNS Diseases

PeptiDream and Takeda Expand its Research and License Agreement to Develop Peptide Drug Conjugates Targeting CNS Diseases

July 28, 2021

Roche Signs a License Agreement with Dyno to Develop AVV Gene Therapy for ~$1.8B

Roche Signs a License Agreement with Dyno to Develop AVV Gene Therapy for ~$1.8B

October 15, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us